Adagene Inc. Strikes Deal to Sell Depositary Shares
Company Announcements

Adagene Inc. Strikes Deal to Sell Depositary Shares

Adagene, Inc. (ADAG) has released an update.

Adagene Inc. has entered into a sales agreement with Leerink Partners LLC to issue and sell American Depositary Shares (ADSs), each representing 1.25 ordinary shares, through a time-to-time sales arrangement. The ADSs will be sold pursuant to a registration statement that became effective in May 2022, with sales parameters detailed in a prospectus supplement. This strategic move allows Adagene to potentially raise capital flexibly, depending on market conditions and their operational needs.

For further insights into ADAG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAdagene Unveils Promising Data for Cancer Therapy
TheFlyAdagene presents data on ADG126 at SITC Annual Meeting
TipRanks Auto-Generated NewsdeskAdagene’s ADG126 Shows Promise in MSS CRC Therapy
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App